LPTX
Price
$0.35
Change
+$0.02 (+6.06%)
Updated
Jul 16 closing price
Capitalization
14.5M
SRPT
Price
$18.38
Change
+$0.17 (+0.93%)
Updated
Jul 16 closing price
Capitalization
1.81B
13 days until earnings call
Interact to see
Advertisement

LPTX vs SRPT

Header iconLPTX vs SRPT Comparison
Open Charts LPTX vs SRPTBanner chart's image
Leap Therapeutics
Price$0.35
Change+$0.02 (+6.06%)
Volume$228.97K
Capitalization14.5M
Sarepta Therapeutics
Price$18.38
Change+$0.17 (+0.93%)
Volume$13.01M
Capitalization1.81B
LPTX vs SRPT Comparison Chart in %
Loading...
LPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LPTX vs. SRPT commentary
Jul 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LPTX is a StrongBuy and SRPT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 17, 2025
Stock price -- (LPTX: $0.35 vs. SRPT: $18.38)
Brand notoriety: LPTX: Not notable vs. SRPT: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LPTX: 14% vs. SRPT: 123%
Market capitalization -- LPTX: $14.5M vs. SRPT: $1.81B
LPTX [@Biotechnology] is valued at $14.5M. SRPT’s [@Biotechnology] market capitalization is $1.81B. The market cap for tickers in the [@Biotechnology] industry ranges from $300.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SRPT’s FA Score shows that 0 FA rating(s) are green whileLPTX’s FA Score has 0 green FA rating(s).

  • SRPT’s FA Score: 0 green, 5 red.
  • LPTX’s FA Score: 0 green, 5 red.
According to our system of comparison, LPTX is a better buy in the long-term than SRPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LPTX’s TA Score shows that 6 TA indicator(s) are bullish while SRPT’s TA Score has 5 bullish TA indicator(s).

  • LPTX’s TA Score: 6 bullish, 4 bearish.
  • SRPT’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both LPTX and SRPT are a good buy in the short-term.

Price Growth

LPTX (@Biotechnology) experienced а +2.73% price change this week, while SRPT (@Biotechnology) price change was -5.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.56%. For the same industry, the average monthly price growth was +10.24%, and the average quarterly price growth was +39.21%.

Reported Earning Dates

LPTX is expected to report earnings on May 13, 2025.

SRPT is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+2.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRPT($1.81B) has a higher market cap than LPTX($14.5M). SRPT (-84.884) and LPTX (-87.826) have similar YTD gains . LPTX has higher annual earnings (EBITDA): -71.67M vs. SRPT (-106.51M). SRPT has more cash in the bank: 523M vs. LPTX (32.7M). LPTX has less debt than SRPT: LPTX (154K) vs SRPT (1.34B). SRPT has higher revenues than LPTX: SRPT (2.23B) vs LPTX (0).
LPTXSRPTLPTX / SRPT
Capitalization14.5M1.81B1%
EBITDA-71.67M-106.51M67%
Gain YTD-87.826-84.884103%
P/E RatioN/A27.21-
Revenue02.23B-
Total Cash32.7M523M6%
Total Debt154K1.34B0%
FUNDAMENTALS RATINGS
SRPT vs LPTX: Fundamental Ratings
SRPT
LPTX
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
38
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9599
PRICE GROWTH RATING
1..100
9894
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
4650

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LPTX's Valuation (38) in the Biotechnology industry is in the same range as SRPT (62). This means that LPTX’s stock grew similarly to SRPT’s over the last 12 months.

LPTX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as SRPT (100). This means that LPTX’s stock grew similarly to SRPT’s over the last 12 months.

SRPT's SMR Rating (95) in the Biotechnology industry is in the same range as LPTX (99). This means that SRPT’s stock grew similarly to LPTX’s over the last 12 months.

LPTX's Price Growth Rating (94) in the Biotechnology industry is in the same range as SRPT (98). This means that LPTX’s stock grew similarly to SRPT’s over the last 12 months.

LPTX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as SRPT (100). This means that LPTX’s stock grew similarly to SRPT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LPTXSRPT
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
70%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
77%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
74%
MACD
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
70%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 8 days ago
74%
Declines
ODDS (%)
Bearish Trend 15 days ago
90%
Bearish Trend 6 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
67%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
LPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PWOD31.740.33
+1.05%
Penns Woods Bancorp
APP355.502.54
+0.72%
Applovin Corp
YEXT8.08-0.01
-0.12%
Yext
IOSP84.53-0.55
-0.65%
Innospec
KZIA10.19-0.61
-5.65%
Kazia Therapeutics Limited

LPTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, LPTX has been loosely correlated with SABS. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if LPTX jumps, then SABS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LPTX
1D Price
Change %
LPTX100%
+4.57%
SABS - LPTX
47%
Loosely correlated
+9.84%
INKT - LPTX
42%
Loosely correlated
-17.49%
AXON - LPTX
40%
Loosely correlated
-0.42%
TECX - LPTX
39%
Loosely correlated
+5.27%
AMRN - LPTX
35%
Loosely correlated
+0.44%
More

SRPT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SRPT has been loosely correlated with ALZN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if SRPT jumps, then ALZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRPT
1D Price
Change %
SRPT100%
+0.93%
ALZN - SRPT
49%
Loosely correlated
+11.36%
AXON - SRPT
43%
Loosely correlated
-0.42%
SYRE - SRPT
42%
Loosely correlated
+5.81%
XNCR - SRPT
42%
Loosely correlated
+4.62%
DYN - SRPT
41%
Loosely correlated
+12.68%
More